Publicacions (200) Publicacions de JAVIER DE LAS RIVAS SANZ

2024

  1. Stratification of Colorectal Patients Based on Survival Analysis Shows the Value of Consensus Molecular Subtypes and Reveals the CBLL1 Gene as a Biomarker of CMS2 Tumours

    International Journal of Molecular Sciences, Vol. 25, Núm. 3

2023

  1. Analysis of asymptomatic Drosophila models for ALS and SMA reveals convergent impact on functional protein complexes linked to neuro-muscular degeneration

    BMC Genomics, Vol. 24, Núm. 1

  2. Comparative Analysis of Cell Mixtures Deconvolution and Gene Signatures Generated for Blood, Immune and Cancer Cells

    International Journal of Molecular Sciences, Vol. 24, Núm. 13

  3. Exploring High-Throughput Immunoassays for Biomarker Validation in Rheumatic Diseases in the Context of the Human Proteome Project

    Journal of Proteome Research, Vol. 22, Núm. 4, pp. 1105-1115

  4. Grand challenges in bioinformatics education and training

    Nature Biotechnology, Vol. 41, Núm. 8, pp. 1171-1174

  5. Identification of a gene expression signature associated with breast cancer survival and risk that improves clinical genomic platforms

    Bioinformatics Advances, Vol. 3, Núm. 1

  6. Immune stress suppresses innate immune signaling in preleukemic precursor B-cells to provoke leukemia in predisposed mice

    Nature Communications, Vol. 14, Núm. 1

  7. METTL1 promotes tumorigenesis through tRNA-derived fragment biogenesis in prostate cancer

    Molecular cancer, Vol. 22, Núm. 1, pp. 119

  8. Systematic Evaluation of Antigenic Stimulation in Chronic Lymphocytic Leukemia: Humoral Immunity as Biomarkers for Disease Evolution

    Cancers, Vol. 15, Núm. 3

  9. Whole-Genome Doubling as a source of cancer: how, when, where, and why?

    Frontiers in Cell and Developmental Biology, Vol. 11

2022

  1. A gene signature derived from the loss of cdkn1a (P21) is associated with CMS4 colorectal cancer

    Cancers, Vol. 14, Núm. 1

  2. Biological interacting units identified in human protein networks reveal tissue-functional diversification and its impact on disease

    Computational and Structural Biotechnology Journal, Vol. 20, pp. 3764-3778

  3. Eltrombopag increases the hematopoietic supporting ability of mesenchymal stem/stromal cells

    Therapeutic Advances in Hematology, Vol. 13

  4. Erratum: Ten simple rules for organizing a bioinformatics training course in low- and middle-income countries (PLoS Computational Biology (2021) 17:8 (e1009218) DOI: 10.1371/journal.pcbi.1009218)

    PLoS Computational Biology

  5. SARS-CoV-2 Infection Triggers Auto-Immune Response in ARDS

    Frontiers in Immunology, Vol. 13

  6. Transient Inhibition of the JAK/STAT Pathway Prevents B-ALL Development in Genetically Predisposed Mice

    Cancer research, Vol. 82, Núm. 6, pp. 1098-1109

  7. Unravelling soluble immune checkpoints in chronic lymphocytic leukemia: Physiological immunomodulators or immune dysfunction

    Frontiers in Immunology, Vol. 13

2021

  1. 40 years of RAS-a historic overview

    Genes, Vol. 12, Núm. 5

  2. Cancer drug resistance induced by EMT: novel therapeutic strategies

    Archives of Toxicology, Vol. 95, Núm. 7, pp. 2279-2297

  3. Cancer-associated fibroblast-derived gene signatures determine prognosis in colon cancer patients

    Molecular Cancer